News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program Michael O'Riordan October 29, 2018
News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016